MEDEZE Reinforces Its Position as a Leader in Future Medical Innovation Wins “The Most Innovative” Award at Future Trends Awards 2026

02.03.2026

MEDEZE Reinforces Its Position as a Leader in Future Medical Innovation Wins “The Most Innovative” Award at Future Trends Awards 2026

Medeze Group Public Company Limited (MEDEZE) has received “The Most Innovative” Award at the Future Trends Awards 2026, recognizing the company as an outstanding organization in innovation. The award reflects MEDEZE’s strong capability in developing innovative solutions and its commitment to advancing the medical industry toward international standards.

Dr. Veerapol Khemarangsan, Chief Executive Officer of Medeze Group Public Company Limited (MEDEZE), revealed that the company was honored with The Most Innovative Award at the Future Trends Awards 2026, an event established to recognize organizations and leaders with forward-looking vision who are capable of developing innovation, driving transformation, and elevating industries in line with global future trends.

Receiving The Most Innovative Award at the Future Trends Awards 2026 represents another proud milestone for the organization and serves as a testament to the dedication of the entire MEDEZE team in continuously developing medical innovations.

The award also highlights MEDEZE’s excellence in advancing healthcare and medical technologies. The company places strong emphasis on research and development investment, the integration of modern technologies into its service processes, and the development of high-quality medical products and solutions that meet international standards to support the growing demand for healthcare services in the era of a health-conscious society.

This recognition not only reflects the organization’s innovative capabilities but also marks another significant step in strengthening confidence among clients, investors, and business partners. It further reinforces MEDEZE’s strategic direction to become a regional leader in medical and healthcare innovation, while driving stable and sustainable growth in the future.

MEDEZE is a leader in stem cell banking, hair follicle cell banking, and immune cell potential analysis, covering services in both precision medicine and preventive medicine. The company also operates one of the largest world-class stem cell laboratories in Southeast Asia, certified with Cleanroom Class 100 by the National Environmental Balancing Bureau (NEBB), United States, and compliant with the standards of the Association for the Advancement of Blood & Biotherapies (AABB), in alignment with global trends emphasizing healthcare and wellness.

“Innovation is a key mechanism for driving sustainable organizational growth. At MEDEZE, we place strong emphasis on developing knowledge, technologies, and integrated service systems, while continuously expanding collaboration with partners both domestically and internationally. These efforts strengthen our competitive capabilities and help elevate Thailand’s medical industry to the global stage,” said Dr. Veerapol

MEDEZE Reinforces Its Position as a Leader in Future Medical Innovation Wins “The Most Innovative” Award at Future Trends Awards 2026

IR Press Releases